VYNE Therapeutics
VYNE
VYNE
44 hedge funds and large institutions have $5.63M invested in VYNE Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
59% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 17
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
44
Holding in Top 10
–
Calls
$88K
Puts
–
Top Buyers
| 1 | +$91K | |
| 2 | +$77.4K | |
| 3 | +$49K | |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$42K |
| 5 |
Renaissance Technologies
New York
|
+$39.4K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$498K | |
| 3 | -$222K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$169K |
| 5 |
Goldman Sachs
New York
|
-$118K |